Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study.

ABSTRACT:

Background

Magnesium oxide (MgO), an antacid and laxative, is widely used in Japan to treat constipation and peptic ulcers. Because serum Magnesium (Mg) levels are elevated in elderly and/or patients with renal failure, its periodic monitoring is recommended for patients prescribed MgO, in order to prevent MgO-induced hypermagnesemia. However, there is little information regarding the factors contributing to the development of MgO-induced hypermagnesemia. In the present study, we retrospectively investigated the risk factors of hypermagnesemia in patients prescribed MgO.

Methods

Data of 3258 patients hospitalized in Mie University Hospital between October 2015 and September 2017, who were prescribed MgO tablets, were extracted from the electronic medical records. According t

SUBMITTER: Wakai E 

PROVIDER: S-EPMC6373027 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature